ALFA Filings
Every announcement, straight from the exchange
Every Aspira Pathlab & Diagnostics other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
4 announcements with these filters
Aspira Pathlab & Diagnostics Ltd has filed its quarterly shareholding pattern for the quarter ended September 30, 2026, in compliance with SEBI Listing Regulations.
Aspira Pathlab & Diagnostics has dispatched the annual report web-link to shareholders who haven't registered their email addresses, in compliance with SEBI Regulation 36(1)(b).
Aspira Pathlab & Diagnostics Ltd has filed its quarterly shareholding pattern for the period ended June 30, 2026, as per regulatory requirements.
Aspira Pathlab & Diagnostics filed its Annual Secretarial Compliance Report for FY2026. The report by independent auditors confirms company compliance with SEBI regulatory requirements.